An epigenetic signature of advanced colorectal cancer metastasis

[1]  E. Amador,et al.  Colorectal liver metastasis: molecular mechanism and interventional therapy , 2022, Signal Transduction and Targeted Therapy.

[2]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[3]  M. Eccles,et al.  Epigenetic basis and targeting of cancer metastasis. , 2021, Trends in cancer.

[4]  Yue Wu,et al.  Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases , 2021, Scandinavian journal of immunology.

[5]  M. Newton,et al.  Validation of genetic classifiers derived from mouse and human tumors to identify molecular subtypes of colorectal cancer. , 2021, Human pathology.

[6]  Jocelyn F Chen,et al.  The roles of epigenetics in cancer progression and metastasis. , 2021, The Biochemical journal.

[7]  Z. Jie,et al.  Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer , 2021, Oxidative medicine and cellular longevity.

[8]  Jinhua Zhang,et al.  Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis , 2021, International journal of molecular sciences.

[9]  Jiantao Zhang,et al.  Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods , 2021, Scientific Reports.

[10]  Baoyu Chen,et al.  Activation of TC10-Like Transcription by Lysine Demethylase KDM4B in Colorectal Cancer Cells , 2021, Frontiers in Cell and Developmental Biology.

[11]  Huafeng Zhang,et al.  Metabolic reprogramming and epigenetic modifications on the path to cancer , 2021, Protein & Cell.

[12]  Ashley M. Laughney,et al.  Cancer metastasis as a non-healing wound , 2021, British Journal of Cancer.

[13]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[14]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[15]  Euan J. Rodger,et al.  The epigenetic landscape of circulating tumour cells. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[16]  Yibin Kang,et al.  Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities , 2020, Genes & development.

[17]  Z. Werb,et al.  Concepts of extracellular matrix remodelling in tumour progression and metastasis , 2020, Nature Communications.

[18]  Jeffrey S. Morris,et al.  Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer , 2020, Gut.

[19]  Zheng Jiang,et al.  Zinc finger and BTB domain-containing 7C (ZBTB7C) expression as an independent prognostic factor for colorectal cancer and its relevant molecular mechanisms. , 2020, American journal of translational research.

[20]  Qiaoyan Liang,et al.  VCAM1 Promotes Tumor Cell Invasion and Metastasis by Inducing EMT and Transendothelial Migration in Colorectal Cancer , 2020, Frontiers in Oncology.

[21]  Henry W. Long,et al.  Prostate cancer reactivates developmental epigenomic programs during metastatic progression , 2020, Nature Genetics.

[22]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[23]  Euan J. Rodger,et al.  EZH2 cooperates with DNA methylation to downregulate key tumour suppressors and interferon gene signatures in melanoma. , 2020, The Journal of investigative dermatology.

[24]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[25]  C. Zahnow,et al.  Epigenetic therapy inhibits metastases by disrupting premetastatic niches , 2020, Nature.

[26]  M. Janiszewska,et al.  Cell adhesion in cancer: Beyond the migration of single cells , 2020, The Journal of Biological Chemistry.

[27]  E. Stoffel,et al.  Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. , 2020, Gastroenterology.

[28]  X. Dang,et al.  Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  A. Chatterjee,et al.  Gene-Specific Targeting of DNA Methylation in the Mammalian Genome , 2019, Cancers.

[30]  C. Chee,et al.  Making sense of adjuvant chemotherapy in colorectal cancer. , 2019, Journal of gastrointestinal oncology.

[31]  Hanshao Liu,et al.  Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin , 2019, Journal of molecular cell biology.

[32]  Hongmei Yu,et al.  TIPE1 Impairs Stemness Maintenance in Colorectal Cancer Through Directly Targeting β-catenin. , 2019, Carcinogenesis.

[33]  G. Torzilli,et al.  Macrophages in Colorectal Cancer Liver Metastases , 2019, Cancers.

[34]  Euan J. Rodger,et al.  Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy. , 2019, Trends in immunology.

[35]  A. Krieg,et al.  KDM4B: A Nail for Every Hammer? , 2019, Genes.

[36]  Jacqueline A. Hall,et al.  A framework for the development of effective anti-metastatic agents , 2018, Nature Reviews Clinical Oncology.

[37]  Lu Wen,et al.  Single-cell multiomics sequencing and analyses of human colorectal cancer , 2018, Science.

[38]  Michael P. Snyder,et al.  Longitudinal personal DNA methylome dynamics in a human with a chronic condition , 2018, Nature Medicine.

[39]  Euan J. Rodger,et al.  Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma , 2018, iScience.

[40]  A. Durán,et al.  The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer , 2018, Cell reports.

[41]  T. Fernández-Villa,et al.  The role of EZH2 in overall survival of colorectal cancer: a meta-analysis , 2017, Scientific Reports.

[42]  Euan J. Rodger,et al.  Epigenetic drivers of tumourigenesis and cancer metastasis. , 2017, Seminars in cancer biology.

[43]  Sebastian Schmeier,et al.  Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer , 2017, Scientific Reports.

[44]  Michael P. Schroeder,et al.  A DNA methylation map of human cancer at single base-pair resolution , 2017, Oncogene.

[45]  Doron Lancet,et al.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards , 2017, Database J. Biol. Databases Curation.

[46]  Mukesh Verma,et al.  Epigenetic Biomarkers in Colorectal Cancer , 2016, Molecular Diagnosis & Therapy.

[47]  Jinhui Wang,et al.  Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia , 2017, Oncogene.

[48]  R. Weinberg,et al.  Emerging Biological Principles of Metastasis , 2017, Cell.

[49]  Johannes G. Reiter,et al.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer , 2017, Nature Genetics.

[50]  E. Batlle,et al.  Determinants of metastatic competency in colorectal cancer , 2017, Molecular oncology.

[51]  Euan J. Rodger,et al.  Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis , 2016, Oncotarget.

[52]  G. Meijer,et al.  Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence , 2016, British Journal of Cancer.

[53]  M. Esteller,et al.  Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer. , 2016, Gastroenterology.

[54]  Christina Wu,et al.  Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others. , 2016, Journal of gastrointestinal oncology.

[55]  H. Brenner,et al.  Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review , 2016, Clinical Epigenetics.

[56]  C. Karapetis,et al.  Colorectal cancer: Metastases to a single organ. , 2015, World journal of gastroenterology.

[57]  Trevor J Pugh,et al.  DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts , 2015, Cell.

[58]  M. Peinado,et al.  Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer , 2015, Epigenetics & Chromatin.

[59]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[60]  Ian M. Morison,et al.  DMAP: differential methylation analysis package for RRBS and WGBS data , 2014, Bioinform..

[61]  A. Rustgi,et al.  IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. , 2013, Carcinogenesis.

[62]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[63]  F. Holstege,et al.  PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. , 2013, Neoplasia.

[64]  I. Tomlinson,et al.  Whole-genome methylation analysis of benign and malignant colorectal tumours , 2013, The Journal of pathology.

[65]  Ian M. Morison,et al.  Technical Considerations for Reduced Representation Bisulfite Sequencing with Multiplexed Libraries , 2012, Journal of biomedicine & biotechnology.

[66]  Matthew T. Maurano,et al.  Widespread plasticity in CTCF occupancy linked to DNA methylation , 2012, Genome research.

[67]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[68]  Euan J. Rodger,et al.  Comparison of alignment software for genome-wide bisulphite sequence data , 2012, Nucleic acids research.

[69]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[70]  F. Liu,et al.  EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. , 2010, World journal of gastroenterology.

[71]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[72]  K. Syrigos,et al.  Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. , 2001, European journal of cancer.

[73]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[74]  A. Chatterjee,et al.  Strategy for RNA-Seq Experimental Design and Data Analysis. , 2023, Methods in molecular biology.

[75]  A. Chatterjee,et al.  Editing of DNA Methylation Patterns Using CRISPR-Based Tools. , 2022, Methods in molecular biology.

[76]  Euan J. Rodger,et al.  Generating Sequencing-Based DNA Methylation Maps from Low DNA Input Samples. , 2022, Methods in molecular biology.

[77]  Ti Zhang,et al.  Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[78]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[79]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.